
Opinion|Videos|May 22, 2024
Considerations for Maintenance Therapy in the Community Oncology Setting
Key opinion leaders address the importance of coordination between academic hospital providers and community oncologists when transitioning from initiation of bispecific antibodies at a tertiary hospital to maintenance therapy in the community oncology setting.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
4
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
5
















































































































































































































